COLESTID Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
When do Colestid patents expire, and what generic alternatives are available?
Colestid is a drug marketed by Pfizer and is included in two NDAs.
The generic ingredient in COLESTID is colestipol hydrochloride. There are two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Colestid
A generic version of COLESTID was approved as colestipol hydrochloride by IMPAX LABS on May 2nd, 2006.
Summary for COLESTID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 16 |
| Clinical Trials: | 1 |
| Patent Applications: | 571 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for COLESTID |
| What excipients (inactive ingredients) are in COLESTID? | COLESTID excipients list |
| DailyMed Link: | COLESTID at DailyMed |
Recent Clinical Trials for COLESTID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Washington | Phase 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for COLESTID
US Patents and Regulatory Information for COLESTID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | COLESTID | colestipol hydrochloride | GRANULE;ORAL | 017563-003 | Sep 22, 1995 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pfizer | COLESTID | colestipol hydrochloride | GRANULE;ORAL | 017563-004 | Sep 22, 1995 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pfizer | COLESTID | colestipol hydrochloride | TABLET;ORAL | 020222-001 | Jul 19, 1994 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for COLESTID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer | COLESTID | colestipol hydrochloride | TABLET;ORAL | 020222-001 | Jul 19, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for COLESTID
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2023 - 2024
NCE-1 Patent Challenge Dates 2023 - 2024
ClinicalTrialExchange - Connecting volunteers and trials
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2023, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
